Revolution Medicines, Inc.
RVMD
$36.63
-$0.64-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.43% | 23.55% | 90.54% | 74.90% | 87.24% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 24.34% | 52.89% | 170.53% | 237.02% | 186.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 23.44% | 23.86% | 91.53% | 76.20% | 87.40% |
|
|
|||||
| Total Current Assets | 23.44% | 23.86% | 91.53% | 76.20% | 87.40% |
| Net Property, Plant & Equipment | 43.09% | 41.80% | 35.07% | 36.95% | 37.14% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.86% | -1.85% | -1.84% | -1.83% | -1.82% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 134.08% | 74.58% | -4.22% | 113.91% | 59.46% |
| Total Assets | 23.95% | 24.09% | 79.12% | 68.43% | 77.81% |
|
|
|||||
| Total Accounts Payable | 46.72% | -11.91% | -17.45% | -1.56% | 62.61% |
| Total Accrued Expenses | 85.89% | 35.64% | 54.46% | 58.80% | 94.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 58.88% | 74.68% | 45.89% | 45.72% | 37.97% |
| Total Finance Division Other Current Liabilities | -12.50% | -85.04% | 166.25% | 87.71% | -59.37% |
| Total Other Current Liabilities | -12.50% | -85.04% | 166.25% | 87.71% | -59.37% |
| Total Current Liabilities | 69.22% | 13.95% | 29.60% | 34.94% | 71.54% |
|
|
|||||
| Total Current Liabilities | 69.22% | 13.95% | 29.60% | 34.94% | 71.54% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 51.97% | 52.62% | 37.16% | 37.44% | 38.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -22.24% | -43.96% | 81.69% | -28.84% | 6.80% |
| Total Liabilities | 57.03% | 24.45% | 34.01% | 32.70% | 51.12% |
|
|
|||||
| Common Stock & APIC | 35.14% | 35.04% | 71.16% | 67.11% | 73.06% |
| Retained Earnings | -55.64% | -52.75% | -58.09% | -59.83% | -62.94% |
| Treasury Stock & Other | 242.49% | 142.83% | 537.66% | -48.92% | -115.47% |
| Total Common Equity | 20.44% | 24.04% | 87.03% | 73.91% | 81.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.44% | 24.04% | 87.03% | 73.91% | 81.21% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.44% | 24.04% | 87.03% | 73.91% | 81.21% |
|
|
|||||